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Abstract
Introduction: Home-based oxygen therapy (long-term oxygen therapy, LTOT) uses two sources of oxygen: stationary
oxygen concentrator (OC) or portable liquid oxygen system (LO). Polish National Healthcare System reimburses only
stationary oxygen sources for home therapy.
The aim of the study was to analyse the effects of switching from OC to LO in patients on LTOT.
Material and methods: The study involved 30 patients qualified for home-based LTOT. Analysed parameters included
degree of dyspnoea (MRC, Borg scale), exercise tolerance (6MWT), physical fitness, duration of daily oxygen therapy use,
peripheral blood status, lung function tests, number of exacerbations and health-related quality of life (SGRQ). Analyses were
performed before initiation of LTOT, after 6 months of therapy using OC and 6 months later, following switch to LO.
Results: During the first six months of therapy, a decrease in red blood cell count (RBC) from 5.4 to 5.1 (p<0.0001) and in
haematocrit value (Ht) from 50.1% to 47.8% (p< 0.0001) was observed, alongside an increase in 6MWT distance from
337.7 m to 378.7 m (p< 0.0001) and improved SGRQ score from 72.1 to 64.4 points (p< 0.0001).
Liquid oxygen therapy resulted in further improvement of the analysed variables: RBC reduction from 5.1 to 4.8 (p< 0.0001),
Ht decrease from 47.8% to 44.3% (p< 0.0001), prolongation of 6MWT distance from 378.7 m to 413 m (p< 0.0001), and
improvement in SGRQ score from 64.4 to 54.9 points (p< 0.0001). A significant increase in daily oxygen breathing hours,
from 13.7 to 18.9 hours (p< 0.0001), was also observed.
Results: Portable liquid oxygen sources facilitate oxygen therapy both at home and outdoors, increasing the number of
oxygen breathing hours and thus improving blood cell counts, exercise tolerance, and health-related quality of life.
Key words: liquid oxygen, LTOT, oxygen therapy, respiratory insufficiency, quality of life, 6-minute walk test, COPD
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Introduction
Home-based long-term oxygen therapy LTOT)
is an established and life-prolonging treatment me-
thod in patients with chronic respiratory insuffi-
ciency. Two types of oxygen sources may be used
for LTOT: oxygen concentrator (OC) and liquid
oxygen source (LO). Oxygen concentrators are in-
expensive but stationary, thus limiting the patients
daily mobility range. Liquid oxygen is a more
expensive but much more convenient oxygen so-
urce from a patients perspective, as it is silent, does
not require an external power supply system, per-
mits application of high oxygen flow (of over 5 L/
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min), and can be used outdoors, when using por-
table containers.
Oxygen therapy in outdoor conditions is be-
lieved to improve the patients self-sufficiency and
facilitate professional activity and participation in
family life and social activities [1]. It also incre-
ases duration of daily oxygen breathing periods,
as suggested by studies of small patient groups [2,
3]. Big population studies in national patient co-
horts, however, did not confirm these results [4].
The Polish healthcare system reimburses only
OC therapy [5]. In 2001, the Centre for LTOT in
Bydgoszcz was the first institution in the country
to introduce liquid oxygen therapy systems for
selected patients on LTOT as part of the current
national reimbursement system. The Kujawy-Po-
meranian region is at present the only one in Po-
land to offer selected patients liquid oxygen sys-
tems as part of LTOT. The authors intended to pre-
sent in the current study their own experience of
LO in LTOT patients.
The aim of the study was to analyse the im-
pact of oxygen therapy using liquid gas sources
upon the intensity of dyspnoea, exercise toleran-
ce, self-dependence, duration of out-of-home acti-
vity, peripheral blood status, functional lung tests,
number of disease exacerbations, and compliance
to recommendations concerning the number of
oxygen breathing hours. Increased duration of oxy-
gen breathing periods and the possibility of stay-
ing outdoors was supposed to improve the quality
of life of patients with chronic respiratory insuffi-
ciency who were qualified for LTOT.
Material and methods
The study had a prospective design, and eva-
luation was done every 6 months. The analysed
cohort included patients with chronic respiratory
insufficiency treated between November 2001
and October 2011 in the Regional Centre for
LTOT of the Kujawy-Pomeranian Regional Pul-
monology Centre in Bydgoszcz. The institution
had a contract with a company delivering LTOT
devices, which enables them to provide some
patients with liquid oxygen sources as part of the
institutional contract with the regional branch
of the National Healthcare System. A liquid oxy-
gen system from CryopAL was used. The device
includes two independent components which the
patient receives for home use. These are: a 44-
litre stationary oxygen container FREELOX 2,
providing oxygen supply for 1014 days of con-
stant use, and a small portable 1.2 L FREELOX
container, providing oxygen supply for outdoor
use for several hours, depending on the gas flow
rate. The portable 1.2 L container can provide
oxygen supply for 9 hours, with 1.5 L/min flow,
7 hours with 2 L/min, and 4 hours 30 minutes if
the oxygen flow is 3 L/min. When filled up with
liquid oxygen, the FREELOX 1.2 L portable con-
tainer had a weight of 3.5 kg. It has an oxygen
gauge meter, which permits the patient to con-
trol the duration of the outdoor activities. The
FREELOX system uses controlled evaporation of
liquid oxygen, and transforms liquid oxygen sto-
red in isolated containers into breathable gas of
temperature close to room conditions, ready for
patient use, and delivers oxygen at a constant
and adjustable flow rate.
All the patients were qualified for LTOT ac-
cording to current criteria, and were provided with
an oxygen concentrator [5]. The following concen-
trators provided by Invacare Corporation were
used: Invacare 5 Sens O2 version RC5LXAQ and
RC5LXO2AQ as well as Platinum S versions
5LX02AWQ, 5LXAW, and 5LX02AW.
The qualification criteria for liquid oxygen
therapy established in the Centre for LTOT in Byd-
goszcz are presented in table 1.
Morante et al. [6] showed that the 6-minute
walk test (6MWT) is a good method of detecting
desaturation (blood saturation decrease) during
daily activity. Therefore, desaturation was measu-
red using this test in the presented group of pa-
tients.
Table 1. Eligibility criteria for the use of liquid oxygen
Inclusion criteria Exclusion criteria
Outdoor activity ‡ 2 hours/day Outdoor activity < 2 h/day
Patient motivated for increasing outdoor activity Lack of motivation for increasing outdoor activity
Patients consent to use oxygen source outdoors Patient ashamed of showing his/her disability; lack of consent to
oxygen therapy outdoors
Adherence to the program of respiratory rehabilitation programme with Patient with PaO2 > 55 mm Hg, no desaturation on exertion
out-of-home oxygen therapy according to given schedule
Desaturation on exertion
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Following 6 months of OC therapy, patients
fulfilling the inclusion criteria but not having any
exclusion criteria were qualified for switching to
liquid oxygen source-based treatment.
During hospitalization in the Department of
Lung Diseases and Respiratory Insufficiency, all
investigations required by the NHS for qualifica-
tion to LTOT were performed in each patient [7].
Those included: peripheral blood analysis, arterial
blood gasometry when breathing atmospheric air,
ECG, antero-posterior and left lateral chest X-ray,
and spirometry. Spirometric tests were performed
using devices from Medical Graphics (USA), Lung
1000-type from the MES company (Cracow), or
MasterScreen device (CareFusion), in adherence to
recommendations of the Polish Respiratory Socie-
ty [8]. Furthermore, gasometry of arterial blood was
also performed when patients were breathing oxy-
gen at a constant predetermined flow rate so as to
reach SpO2 of more than 90%.
Every six months, all patients were revaluated,
and the following tests were performed: tolerance
of exertion by 6MWT (6MWD, 6-minute walk di-
stance) with measurement of walked distance ac-
cording to the 2002 ATS recommendations [9], and
assessment of dyspnoea according to the modified
Medical Research Council (mMRC) scale [10] and
Borg scale [11], assessment of physical fitness using
Katz scale to evaluate basic activities of daily li-
ving (ADL) [12], Lawton scale for assessment of
activities necessary for independent functioning
(Instrumental Activities of Daily Living, IADL) [13]
as well as physical activity assessment according
to the British Thoracic Society [14] (1  normal
unlimited physical activity, 2  limited tolerance
of strenuous activity, retained possibility of non-
strenuous work, 3  limited physical activity, re-
tained self-dependence, 4  limited physical ac-
tivity, limited self-dependence, 5  bed/armchair
immobilization, patient requiring constant care).
The ADL or Katz scale measures a patients
ability to clothe, eat meals, walk, use the toilet, and
take care of personal hygiene as basic elements of
their daily routine. One point is given for each ac-
tivity that the patient is able to perform, thus the
overall score ranges from 0 to 6 points. A total sco-
re of 6 points means that the patient is self-depen-
dent regarding daily basic activities, 4 points me-
ans partial dependence on other persons, and a
score of 2 points represents a patient completely
dependent on others on a daily basis.
The IADL scale is used for assessment of ca-
pability of doing shopping, managing personal fi-
nances, maintaining own household, doing laun-
dry, preparing meals, using public transportation,
using a telephone, and taking drugs prescribed by
a physician. The subjects ability to perform these
activities on their own is assessed in a three-tie-
red scale, with 3 points awarded if the patient can
perform the activity independently, 2 points if
some assistance is needed, and 1 point given to a
person not capable of performing the activity on
his/her own. Overall score ranges from 8 to 24 po-
ints. The higher the score, the greater the patients
ability to exist independently. The IADL scale is
used mainly to assess in detail a patients functio-
ning as well as to monitor the course of the dise-
ase and treatment results.
The patients mood as well as the presence and
intensity of depression symptoms during the last
month were assessed using Beck Depression Inven-
tory (BDI) [15]. A score of over 11 was an impor-
tant indicator that the patient suffers from mood
disturbances or is at risk of becoming depressed.
For evaluation of health-related quality of life, the
St. Georges Respiratory Questionnaire (SGRQ) [16]
was used. The questionnaire consists of 50 qu-
estions grouped in three areas: symptoms (S), acti-
vity (A), and impact on life (I). Based on the answers
to respective questions, scores are assigned and used
to calculate a result representing the patients qu-
ality of life (QoL). The total score (T) from the SGRQ
assessment and scores in respective areas can ran-
ge between 0 (least impairment of QoL) and 100
(greatest impairment of QoL).
Patients filled in the SGRQ on their own,
Beck Depression Inventory was analysed by a
clinical psychologist, and the other scales were
assessed by a qualified nurse. Analyses were
performed before initiation of LTOT, after 6
months of LTOT with the use of OC, and 6 mon-
ths after switching to LO.
Each patient was given a list of physical exerci-
ses, with instructions on how to perform them and
encouragement to start daily walks. The list inclu-
ded exercises aimed at general fitness improvement,
exercises increasing mobility of the chest wall, and
respiratory exercises, developed in accordance with
recommendations concerning respiratory rehabilita-
tion [17]. The duration and intensity of training was
individually adjusted for each patient, depending on
his or her physical capabilities. Most patients were
recommended to exercise for 15 minutes, twice a day.
When qualified for liquid oxygen system use,
patients and their families were trained by a nurse
and a representative of the device deliverer to use
the FREELOX System and to fill the small portable
1.2 L FREELOX container using a 44-litre stationa-
ry FREELOX 2 oxygen repository. Once every three
months, each patient was visited at home by a tra-
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ined nurse, who controlled compliance to the phy-
sicians recommendations and orders, adherence to
physical exercise programme, motivated the pa-
tients to adhere to the recommended duration of
daily oxygen breathing regime, and calculated the
number of LTOT hours based on OC meter readings.
Total number of hours on LTOT and number
of hours with oxygen source spent outdoors were
noted by each patient in respective logs. The pa-
tients visited the Centre for LTOT every 3 months
to perform of the above-mentioned analyses and
for a doctors visit. Each episode of disease exacer-
bation was recorded on a separate chart, including
both episodes treated on an outpatient basis (as
reported by the patients GP in their patient record)
and episodes of hospitalization, as described in
hospital discharge charts.
Statistical analysis
Statistical analysis was performed using Sta-
tistica 7.1 (StatSoft) software.
Variables were reported as mean values, stan-
dard deviation (SD), and median values and were
depicted on histograms (empiric distribution gra-
phs). In order to verify statistical hypotheses, the
following tests were used: Shapiro-Wilks test for
variables with non-normal value distribution, Wil-
coxon non-parametric pair rank test, and non-pa-
rametric U Mann-Whitney test. In order to assess
the significance of QoL changes during oxygen
therapy, a hypothesis was made (and verified) that
the mean changes in scores differ significantly from
the zero value (baseline). For this purpose, Stu-
dents t parametric test for related groups was used
with the assumption of normal value distribution.
The adopted level of significance was p ?0.05, and
critical values for p = 0.05 were taken from respec-
tive distribution tables.
Results
The studied group of 30 patients included 22
men (73.3%) and 8 women. Mean patient age was
49 – 10.4 years. Mean age of male patients was 50.5
years, and of females  48 years.
The main disease leading to respiratory insuf-
ficiency was chronic obstructive pulmonary dise-
ase (COPD) in 20 patients (66.7%), bronchiectases
in 4 patients (13.3%), interstitial lung disease in 3
patients (10%), and other lung diseases (mucovi-
scidosis (cystic fibrosis), kyphoscoliosis, LAM) in
the remaining 3 patients (10%). Seven patients in
the group (23.3%) never smoked tobacco, and 23
persons (76.7%) admitted a past smoking habit.
Tobacco exposure in former smokers was 37 – 17
pack-years on average. Median duration of absti-
nence from smoking until qualification for LTOT was
2.83 – 3.63 years. The main disease duration was
13.42 – 7.32 years. The period from disease diagno-
sis and initiation of LTOT was 9.01 – 8.61 years on
average. The characteristics of the patient population
before onset of LTOT is presented in table 2.
Spirometry and blood gasometry
There were no significant changes in spirome-
try or blood gasometry results under oxygen the-
rapy with OC or LO.
Dyspnoea and physical fitness
Oxygen therapy applied using liquid oxygen
during daily activity reduced dyspnoea and impro-
ved tolerance of exertion. There was significant
Table 2. Characteristics of the study group, including an-
thropometric features, spirometry, blood gaso-
metry, blood counts, 6MWD, MRC, Borg Scale,
BDI, and number of exacerbations in the year
preceding initiation of DLT
Parameter Mean value SD
Body height [cm] 168.72 7.98
Body mass [kg] 82.72 20.47
BMI [kg/m2] 28.67 6.15
PaO2 () O2 [mm Hg] 52.15 3.87
PaCO2 () O2 [mm Hg] 50.01 6.24
pH 7.40 0.03
O2 saturation (%) 85.83 3.65
FVC [l] 2.12 0.65
FVC (% predicted) 56.37 15.06
VC [l] 2.29 0.72
VC (%) 57.25 14.10
FEV1 [l] 0.97 0.31
FEV1 (%) 31.59 12.05
FEV1/VC (%) 44.58 15.68
Hb (g%) 15.89 2.34
Ht (%) 50.18 7.75
RBC [106/ìL] 5.40 0.70
6MWD [m] 337.72 116.81
Dyspnoea according to Borg 4.83 0.91
scale (010) (points)
mMRC (04) (grade) 3.63 0.49
BDI (063) (points) 14 8.15
Number of exacerbations per year 3.67 2.01
BMI  body mass index; O2 saturation  oxygen saturation in arterial blood; FVC
 forced vital capacity; FEV1  forced expiratory volume in one second; RBC 
red blood cell count; 6MWD  6-minute walking distance test; mMRC  modified
intensity of dyspnoea Medical Research Council scale; BDI  Beck Depression
Inventory; SD  standard deviation
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improvement in feeling of dyspnoea as assessed by
patients using the mMRC scale (mean decrease
from 3.53 to 3.17 grade, p <0.001) and Borg scale
(mean decrease from 4.83 to 3.8 points, p <0.0001).
Physical fitness also improved, as assessed by ADL
scale (increase from 5.1 to 5.6 points, p <0.0001),
IADL scale (increment from 18.27 to 20.4 points,
p < 0.0001) and degree of fitness according to BTS
(mean decrease from 3.2 to 2.5 grade), p <0.0001).
Figure 1 presents the impact of LO therapy on
patients mood, the presence and intensity of de-
pression symptoms as measured by BDI, intensity
of dyspnoea according to MRC and Borg scale,
daily activity measured by ADL and IADL scale,
as well as degree of fitness according to BTS when
compared to results under therapy with OC.
Unfortunately, only 14 (46.7%) patients de-
monstrated compliance to the physical exercise
training programme; the other patients did the
exercises only sporadically. There was no differen-
ce in regularity of training between different sour-
ces of oxygen for therapy. On the other hand, all
patients using liquid oxygen increased their daily
activity and duration of out-of-home stay when
using an oxygen source.
Peripheral blood parameters, daily duration
of LTOT, duration of out-of-home stay,
number of exacerbations
During the first six months of therapy with OC,
patients demonstrated a significant decrease in red
blood cell count from 5.40 – 0.70 to 5.15 – 0.49 (p
<0.0001), haematocrit from 50.18 – 7.75% to 47.78
– 5.62% (p <.0.0001), and haemoglobin from 15.89
– 2.34 to 15.1 – 1.68 g% (p <0.0001). During the
following 6 months of LO therapy, all the patients
used oxygen therapy daily for >15 hours/day, with
a significant increase of therapy duration from the
mean value of 13.73 – 2.10 to 18.93 – 1.84 hours/
day (p <0.0001), increased number of hours of out-
of-home stay on average from 3.10 – 1.45 to 4.60 –
1.22 (p <0.0001), and further improvement of blo-
od parameters as reflected by a decrease in RBC from
5.15 – 0.49 to 4.80 – 0.38 (p <0.0001), decrease in
haematocrit from 47.78 – 5.62 % to 44.32 – 4.10%
(p <0.0001), and in haemoglobin from 15.1 – 1.68
to 14.28 – 1.25 g% (p <0.0001). Furthermore, the-
re were fewer episodes of disease exacerbation, a
mean decrease from 1.53 to 0.57 (p <0.0001), and
lesser intensity of depression symptoms according
to BDI, from mean score of 13.27 points to 9.1 po-
ints (p <0.0001). The greatest improvement in ha-
emoglobin, haematocrit, and red blood cell count
was observed in 11 patients, which at baseline had
features of polyglobulia (with parameters before in-
itiation of LTOT, after 6 months of OC and after fur-
ther 6 months on LO, respectively  Hb: 17.72,
15.33, 15.22g%; Ht: 56.26, 51.65, 47.05%; RBC: 5.88,
5.43, 4.99 × 106/UL).
The impact of LO treatment on blood morpho-
logy as compared to OC is depicted in figure 2.
Figure 3 shows the correlation between source of
oxygen and number of therapy hours per day, and
between duration of out-of-home stay and number
of exacerbations.
Six-minute walking test
After six months of LO therapy, mean walking
distance during 6MWT increased by 34.31 – 15.45
m (p <0.0001). In 18 patients with COPD and bron-
chiectases, who at baseline had 6MWD >350 m,
there was a mean improvement of 42.29 – 6.84 m.
Mean walking distance values in 6MWD test
before initiation of LTOT and under oxygen thera-
py with OC or LO are demonstrated in figure 4.
Quality of life
A significant improvement in health-related
quality of life measured by SGRQ was observed
under oxygen therapy with OC, with further ame-
lioration in all areas of SGRQ when using LO.
Figure 5 depicts the impact of oxygen therapy
with OC or LO upon patients quality of life me-
asured by SGRQ, with its respective areas (symp-
toms, S; activity, A; impact on daily life, I) and glo-
bal QoL measure.
The greatest benefit was observed in the area
of impact on daily life after switching from OC
to LO (14.8 points), which improved overall qu-
ality of life measures (9.47 points). The least dif-
ference was noted in the sphere of activity, with
a difference of less than 4 points (3.51).
Discussion
The presented study is most likely the first
Polish publication reporting the impact of swit-
ching oxygen source (from concentrator to liquid
oxygen) upon physical activity, quality of life, and
general condition of patients requiring home-ba-
sed oxygen treatment. Usage of liquid oxygen gi-
ves a patient the benefit of receiving therapy when
staying outside of home. The United States has
become a pioneer of LO treatment, as one third of
almost a million of patients requiring home-based
oxygen therapy is using LO [18]. The presented
study confirmed earlier observations [19] stating
that LO permits longer oxygen therapy during the
day. The authors also showed a significant incre-
ase in number of oxygen breathing hours (from
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13.73 to 18.93 hours/day, p <0.0001), greater than
in other published reports [20]. Such a difference
can probably be explained by stricter patient qu-
alification. Katsenos et al. analysed a group of ol-
der patients (mean age of 75.4 – 8.8 years), of
whom most did not comply to physicians orders,
as demonstrated by usage of oxygen therapy for ‡
15 hours/day by only 12.9% patients using OC and
42.5% patients with LO systems. Those patients
had higher FEV1 values (mean of 42 – 20.9% on
OC and 39.1 – 19.1% on LO) and blood saturation
before treatment initiation (mean value 90.9 –
4.51%). As many as 16% of patients with ongoing
OC therapy and 20.5% of patients currently using
LO were active smokers in the cited study. It can
therefore be implied that the studied patients did
not have a strong motivation to adhere to medical
orders concerning their oxygen therapy. However,
this study also demonstrated that patients using LO
had a significantly longer daily duration of thera-
py (mean of 12.8 – 5.6 hours/day) when compa-
Figure 1. Mean values of BDI, MRC, Borg scale score, ADL, IADL, and performance status according to BTS in patients under oxygen therapy
with OC and LO; abbreviations explained in the text above
Figure 2. Mean values of Hb, Ht, and RBC in patients under oxygen
therapy with OC and LO; abbreviations explained in the text above
Figure 3. Mean number of hours of oxygen therapy, number of hours
out-of-home stay, number of exacerbations in patients under oxygen
therapy with OC and LO; abbreviations explained in the text above
red to persons using a stationary oxygen source (7.6
– 5.5 hours/day; p <0.001). Similarly to the results
of the presented study, compliance to ‡ 15 hours/
day of oxygen therapy was better when using LO
than with OC systems (p <0.005).
The authors believe that the presented crite-
ria can be applied when elaborating national re-
commendations for qualification for oxygen the-
rapy using OC and LO. Inclusion of 6WMT distan-
ce can also be considered as patients with baseli-
ne 6MW distance >350 m experienced a greater
improvement in tolerance of physical activity in
the presented study.
Patients who qualified in the current study
were young (with mean age 49 – 10.4 years), and
were more likely to execute professional activities,
support families, and fully participate in family
and social life despite their disease. The more ho-
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Figure 5. Impact of oxygen therapy with OC or LO upon patient quality of life measured by SGRQ; abbreviations explained in the text above
urs of oxygen breathing from LO source, the gre-
ater the possibility of spending more active ho-
urs outdoors.
Prolonged daily oxygen therapy resulted in
fewer hours of tissue hypoxia, as reflected indirec-
tly by progressive decrease in haematocrit and si-
gns of polyglobulia. It was shown that secretion of
erythropoietin, hormone stimulation erythropoie-
sis, increases when the partial pressure of oxygen
in arterial blood drops under 60 mm Hg for more
than 120 minutes [21]. This explains why patients
using a stationary oxygen source and experiencing
profound desaturation on exertion [22] have high
haematocrit values. It can be suggested that liquid
oxygen used by patients in the presented analysis
protected them from prolonged hypoxia.
The greatest improvement in the presented
study seems to concern patients quality of life.
Global improvement of health related quality of life
was 9.47 points as measured by St. Georges Re-
spiratory Questionnaire.
Figure 4. Mean values of 6MWD in patients under oxygen therapy
with OC or LO; abbreviations explained in the text above
This is an important issue as no significant
improvement of QoL was previously observed un-
der therapy using a stationary oxygen source when
using the same measurement approach [23].
In the current study, patients experienced not
only a significant improvement in daily activity as
measured by ADL (from 5.1 points to 5.6 points; p
<0.0001) and increased capability of activities ne-
cessary for independent functioning according to
IADL scale (improvement form 18.27 points to 20.4
points; p <0.0001), but also improved fitness accor-
ding to BTS (improvement from 3.2 to 2.5; p
<0.0001). Most patients, when using a portable
oxygen source, could actively take part in family life
and perform non-strenuous work at home or in the
garden (fig. 6). One patient could take part in occu-
pational therapy meetings, and three others were
able to continue their professional activities, which
did not require physical exercise. Their ability to
take part in family and professional life could have
contributed to their improved quality of life, as re-
flected by global SGRQ score and especially when
analysing the impact on life domain, where the
improvement was on average 14.78 points. Effects
such as better mood and lesser intensity of depres-
sion as assessed by BDI (from 13.27 to 9.1 points)
can also be observed. These results can possibly be
explained by a previous feeling of social isolation
due to the necessity of using a stationary oxygen
concentrator for more than 10 hours a day. Another
factor that could explain the patients improved
quality of life in this study was the lower number
of disease exacerbations during 6 months of oxy-
gen therapy when using an LO source. Greater da-
ily activity [24] and longer periods of outdoor stay
[25] also contribute to a better prognosis.
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Liquid oxygen sources became more widely
used in Europe in the beginning of 1980s, when it
was mainly intended to increase the number of
oxygen breathing hours. Qualifications for this mo-
dality of treatment also included young age, heavy
hypoxemia, and signs of right heart side failure
[26]. Initial fears that carrying an oxygen tank can
increase patient energy consumption proved
ungrounded [27].
To sum up, the results of the current study
confirm that use of a liquid oxygen source incre-
ases the duration of daily oxygen breathing thera-
py, reduces the risks of tissue damage by prolon-
ged hypoxemia, and significantly improves the
quality of life in patients with chronic respiratory
insufficiency.
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Figure 6. Patient breathing liquid oxygen from FREELOX 2 portable
container while working in the garden
